Your browser doesn't support javascript.
loading
Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry).
Möbius, Susanne; Schenk, Thomas; Himsel, Danny; Maier, Jacqueline; Franke, Georg-Nikolaus; Saussele, Susanne; Pott, Christiane; Andrikovics, Hajnalka; Meggyesi, Nora; Machova-Polakova, Katerina; Zizkova, Hana; Jurcek, Tomás; Mesanovic, Semir; Zadro, Renata; Gottardi, Enrico; Haenig, Jens; Schuld, Peter; Cross, Nicholas C P; Hochhaus, Andreas; Ernst, Thomas.
Afiliação
  • Möbius S; Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Am Klinikum 1, 07740, Jena, Germany.
  • Schenk T; Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Am Klinikum 1, 07740, Jena, Germany.
  • Himsel D; Abteilung Hämatologie und Internistische Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Am Klinikum 1, 07740, Jena, Germany.
  • Maier J; Abteilung für Hämatologie und internistische Onkologie, Universität Leipzig, Leipzig, Germany.
  • Franke GN; Abteilung für Hämatologie und internistische Onkologie, Universität Leipzig, Leipzig, Germany.
  • Saussele S; III. Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany.
  • Pott C; Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Andrikovics H; National Blood Service, Budapest, Hungary.
  • Meggyesi N; Central Hospital of Southern Pest, Budapest, Hungary.
  • Machova-Polakova K; National Blood Service, Budapest, Hungary.
  • Zizkova H; Central Hospital of Southern Pest, Budapest, Hungary.
  • Jurcek T; Department of Molecular Genetics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Mesanovic S; Department of Molecular Genetics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Zadro R; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Gottardi E; Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic.
  • Haenig J; Pathology Department, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.
  • Schuld P; University Hospital Center Zagreb, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.
  • Cross NCP; Division of Internal Medicine and Hematology, University of Turin, Orbassano, Italy.
  • Hochhaus A; Novartis Oncology, Global Medical Affairs, Basel, Switzerland.
  • Ernst T; Novartis Oncology, Global Medical Affairs, Basel, Switzerland.
J Cancer Res Clin Oncol ; 145(6): 1645-1650, 2019 Jun.
Article em En | MEDLINE | ID: mdl-30941573
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide de Fase Crônica / Inibidores de Proteínas Quinases Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide de Fase Crônica / Inibidores de Proteínas Quinases Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Alemanha